2022 annual financial data
Olema Pharmaceuticals 2022 Operating margin
Olema Pharmaceuticals 2022 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -106,988,000 USD and net income was -102,586,000 USD.
Operating cash flow was -82,065,000 USD.
Get free Olema Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -106,988,000 USD
- Net income
- -102,586,000 USD
- Operating cash flow
- -82,065,000 USD